Participants who preserved muscle could eat 200-300 more calories daily while maintaining their weight loss compared to those who lost significant lean mass
"In the longer term, however, reduced obesity rates among Medicaid enrollees could also result in reduced Medicaid spending on chronic diseases associated with obesity, such as heart disease, Type 2 diabetes and types of cancer," the researchers noted in a KFF news release
However, they arent a one-size-fits-all solution
Possible Side Effects Observed in Research Settings Semaglutide has been explored in laboratory and experimental research settings, and observed responses in some research contexts have included: Nausea Gastrointestinal discomfort Reduced appetite-related observations Vomiting Diarrhea or constipation Bloating or abdominal discomfort Fatigue or lethargy Headaches Injection-site irritation or redness Gastrointestinal & Administration Considerations In some research models, more significant gastrointestinal-related observations have been reported during higher-exposure or administration-escalation protocols
Because retatrutide is not currently approved in the UK, the final cancer warnings, contraindications and safety guidance will only be confirmed if the medicine is reviewed and licensed by regulators